1. Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA;
2. Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology “Seràgnoli” University of Bologna, Bologna, Italy;
3. Department of Lymphoma and Myeloma, The University of Texas, MD Anderson Cancer Center, Houston, TX;
4. Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA;
5. Department of Hematology, Jewish General Hospital, Montreal, QC, Canada;
6. Department of Hematology-Oncology, Hopital Saint Louis, Paris, France;
7. Division of Cancer Sciences, The University of Manchester and The Christie NHS Foundation Trust, Manchester, United Kingdom;
8. Department of Drug Development and Hematology, Institut Gustave Roussy, Villejuif, France;
9. Section of Experimental and Clinical Oncology, Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden;
10. Department of Hematology and Bone Marrow Transplantation, General Hospital of Athens, Athens, Greece;
11. Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan;
12. Department of Internal Medicine, University of Cologne and University Hospital of Cologne, Cologne, Germany;
13. Medical Oncology, Merck & Co, Inc, Kenilworth, NJ; and
14. Department of Medicine, University of Miami Sylvester Comprehensive Cancer Center, Miami, FL